CNSX:SNN - Sunniva Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $4.23 0.00 (0.00 %) (As of 01/17/2019 04:00 PM ET)Previous Close$4.23Today's Range$4.18 - $4.2652-Week Range$7.05 - $16.00Volume60,081 shsAverage Volume44,398 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartHeadlinesOptions Chain Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder. It also provides arthroscopic enabling technologies for healthcare providers comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue. In addition, the company offers trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; robotics-assisted surgery, various products, and technologies to assist in surgical treatment of the ear, nose, and throat; knee implant products for specialized knee replacement procedures; and hip implant products for the reconstruction of hip joints. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration; and advanced wound devices, such as traditional and single-use negative pressure wound therapy and hydrosurgery systems. The company primarily serves the providers of medical and surgical treatments and services. Smith & Nephew plc was founded in 1856 and is headquartered in London, the United Kingdom. Receive SNN News and Ratings via Email Sign-up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange CNSX Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolCNSX:SNN Previous Symbol CUSIPN/A Webwww.smith-nephew.com Phone44 20 7401 7646Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees15,000 Outstanding SharesN/AMarket Cap$0.00 OptionableOptionable Sunniva (CNSX:SNN) Frequently Asked Questions What is Sunniva's stock symbol? Sunniva trades on the CNSX under the ticker symbol "SNN." What price target have analysts set for SNN? 2 Wall Street analysts have issued 12-month price targets for Sunniva's stock. Their forecasts range from $13.00 to $39.49. On average, they anticipate Sunniva's stock price to reach $26.2450 in the next year. This suggests a possible upside of 520.4% from the stock's current price. View Analyst Price Targets for Sunniva. What is the consensus analysts' recommendation for Sunniva? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sunniva in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sunniva. Has Sunniva been receiving favorable news coverage? Media stories about SNN stock have trended very positive on Thursday, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Sunniva earned a media sentiment score of 3.7 on InfoTrie's scale. They also gave news stories about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. Who are some of Sunniva's key competitors? Some companies that are related to Sunniva include Activecare (ACAR), Advanced Oncotherapy (AVO), Airware Labs (AIRW), Anteo Diagnostics (ADO), Aurora Spine (ASG), Avacta Group (AVCT), Azure Healthcare (AZV), Cannabix Technologies (BLOZF), Cochlear (COH), ConvaTec Group (CTEC), Creo Medical Group (CREO), Draegerwerk AG & Co KGaA (DRW3), Electromed (ELMD), Ellex Medical Lasers (ELXMF) and EMvision Medical Devices (EMV). Who are Sunniva's key executives? Sunniva's management team includes the folowing people: Mr. Graham Timothy Baker, CFO & Exec. Director (Age 51)Mr. Namal Nawana, CEO & Exec. Director (Age 48)Mr. Mark Gladwell, Pres of Global Operations (Age 44)Ms. Catheryn O'Rourke, Chief Legal & Compliance Officer (Age 46)Mr. Joe Metzger, Sr. VP of Marketing Services & Communications How do I buy shares of Sunniva? Shares of SNN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Sunniva's stock price today? One share of SNN stock can currently be purchased for approximately $4.23. What is Sunniva's official website? The official website for Sunniva is http://www.smith-nephew.com. How can I contact Sunniva? The company can be reached via phone at 44 20 7401 7646. MarketBeat Community Rating for Sunniva (CNSX SNN)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 35 (Vote Outperform)Underperform Votes: 27 (Vote Underperform)Total Votes: 62MarketBeat's community ratings are surveys of what our community members think about Sunniva and other stocks. Vote "Outperform" if you believe SNN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/17/2019 by MarketBeat.com StaffFeatured Article: What are the benefits of momentum investing?